{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:44:53Z","timestamp":1789767893597,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17-74-30019"],"award-info":[{"award-number":["17-74-30019"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17-74-30019"],"award-info":[{"award-number":["17-74-30019"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17-74-30019"],"award-info":[{"award-number":["17-74-30019"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["17-74-30019"],"award-info":[{"award-number":["17-74-30019"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["&amp;#x041D;&amp;#x0420;17-04-01233A"],"award-info":[{"award-number":["&amp;#x041D;&amp;#x0420;17-04-01233A"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["&amp;#x041D;&amp;#x0420;17-04-01233A"],"award-info":[{"award-number":["&amp;#x041D;&amp;#x0420;17-04-01233A"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The discovery of antibody-mediated catalysis was a breakthrough that showed antibody function is not limited to specific binding interactions, and that immunoglobulins (Igs) may also chemically transform their target antigens. Recently, so-called \u201cnatural catalytic antibodies\u201d have been intimately linked with several pathologies, where they either protect the organism or contribute to the development of autoimmune abnormalities. Previously, we showed that myelin-reactive autoantibodies from patients with multiple sclerosis (MS) and mice with experimental autoimmune encephalomyelitis (EAE) exhibit the ability to recognize and hydrolyse distinct epitopes within myelin basic protein (MBP). Further, the antibody-mediated cleavage of encephalitogenic MBP peptide 81\u2013103, flanked by two fluorescent proteins, can serve as a novel biomarker for MS. Here, we report the next generation of this biomarker, based on the antibody-mediated degradation of a novel chemically synthesized FRET substrate, comprising the fluorophore Cy5 and the quencher QXL680, interconnected by the MBP peptide 81\u201399: Cy5-MBP<jats:sub>81\u201399<\/jats:sub>-QXL680. This substrate is degraded upon incubation with either purified antibodies from MS patients but not healthy donors or purified antibodies and splenocytes from EAE but not from non-immunized mice. Data presented herein suggest the elaboration of potential specific, rapid, and sensitive diagnostic criteria of active progressive MS.<\/jats:p>","DOI":"10.1038\/s41598-018-30938-0","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T11:22:16Z","timestamp":1534504936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostics of autoimmune neurodegeneration using fluorescent probing"],"prefix":"10.1038","volume":"8","author":[{"given":"Yakov","family":"Lomakin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kudriaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9447-9961","authenticated-orcid":false,"given":"Nikita","family":"Kostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Terekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Kaminskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Chernov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taras","family":"Simaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy","family":"Telegin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gabibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2033-9621","authenticated-orcid":false,"suffix":"Jr.","given":"Alexey","family":"Belogurov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"30938_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","volume":"16","author":"A Mizoguchi","year":"2002","unstructured":"Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219\u2013230 (2002).","journal-title":"Immunity"},{"key":"30938_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","volume":"12","author":"B Pulendran","year":"2011","unstructured":"Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat Immunol 12, 509\u2013517 (2011).","journal-title":"Nat Immunol"},{"key":"30938_CR3","doi-asserted-by":"crossref","unstructured":"Gololobov, G. V., Mikhalap, S. V., Starov, A. V., Kolesnikov, A. F. & Gabibov, A. G. DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl Biochem Biotechnol 47, 305\u2013314, discussion 314-305 (1994).","DOI":"10.1007\/BF02787942"},{"key":"30938_CR4","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1073\/pnas.0500586102","volume":"102","author":"S Lacroix-Desmazes","year":"2005","unstructured":"Lacroix-Desmazes, S. et al. High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proceedings of the National Academy of Sciences of the United States of America 102, 4109\u20134113, https:\/\/doi.org\/10.1073\/pnas.0500586102 (2005).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"30938_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jmr.2534","volume":"29","author":"SV Baranova","year":"2016","unstructured":"Baranova, S. V., Buneva, V. N. & Nevinsky, G. A. Antibodies from the sera of HIV-infected patients efficiently hydrolyze all human histones. J Mol Recognit 29, 346\u2013362, https:\/\/doi.org\/10.1002\/jmr.2534 (2016).","journal-title":"J Mol Recognit"},{"key":"30938_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.1585181","volume":"256","author":"AM Shuster","year":"1992","unstructured":"Shuster, A. M. et al. DNA hydrolyzing autoantibodies. Science 256, 665\u2013667 (1992).","journal-title":"Science"},{"key":"30938_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.imlet.2005.10.006","volume":"103","author":"NA Ponomarenko","year":"2006","unstructured":"Ponomarenko, N. A. et al. Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale. Immunology letters 103, 45\u201350, https:\/\/doi.org\/10.1016\/j.imlet.2005.10.006 (2006).","journal-title":"Immunology letters"},{"key":"30938_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/rheumatology\/kep328","volume":"49","author":"YH Yang","year":"2010","unstructured":"Yang, Y. H. et al. Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity. Rheumatology 49, 34\u201342, https:\/\/doi.org\/10.1093\/rheumatology\/kep328 (2010).","journal-title":"Rheumatology"},{"key":"30938_CR9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/jmr.2476","volume":"28","author":"AM Timofeeva","year":"2015","unstructured":"Timofeeva, A. M., Buneva, V. N. & Nevinsky, G. A. Systemic lupus erythematosus: molecular cloning and analysis of 22 individual recombinant monoclonal kappa light chains specifically hydrolyzing human myelin basic protein. J Mol Recognit 28, 614\u2013627, https:\/\/doi.org\/10.1002\/jmr.2476 (2015).","journal-title":"J Mol Recognit"},{"key":"30938_CR10","doi-asserted-by":"publisher","unstructured":"Smirnov, I. V., Belogurov, A. A., Kozyr, A. V. & Gabibov, A. Catalytic Antibodies. 1735-1776 https:\/\/doi.org\/10.1002\/9783527639861.ch42 (2012).","DOI":"10.1002\/9783527639861.ch42"},{"key":"30938_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cbi.2012.10.011","volume":"203","author":"I Smirnov","year":"2013","unstructured":"Smirnov, I. et al. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents. Chem Biol Interact 203, 196\u2013201, https:\/\/doi.org\/10.1016\/j.cbi.2012.10.011 (2013).","journal-title":"Chem Biol Interact"},{"key":"30938_CR12","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1126\/science.7569920","volume":"269","author":"PG Schultz","year":"1995","unstructured":"Schultz, P. G. & Lerner, R. A. From molecular diversity to catalysis: lessons from the immune system. Science 269, 1835\u20131842 (1995).","journal-title":"Science"},{"key":"30938_CR13","doi-asserted-by":"publisher","first-page":"15257","DOI":"10.1074\/jbc.270.25.15257","volume":"270","author":"S Paul","year":"1995","unstructured":"Paul, S. et al. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment. The Journal of biological chemistry 270, 15257\u201315261 (1995).","journal-title":"The Journal of biological chemistry"},{"key":"30938_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1074\/jbc.M116.767582","volume":"292","author":"A Bowen","year":"2017","unstructured":"Bowen, A., Wear, M. P., Cordero, R. J., Oscarson, S. & Casadevall, A. A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides. The Journal of biological chemistry 292, 417\u2013434, https:\/\/doi.org\/10.1074\/jbc.M116.767582 (2017).","journal-title":"The Journal of biological chemistry"},{"key":"30938_CR15","first-page":"521","volume":"39","author":"Y Kit","year":"1996","unstructured":"Kit, Y., Semenov, D. V. & Nevinsky, G. A. Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A. Biochem Mol Biol Int 39, 521\u2013527 (1996).","journal-title":"Biochem Mol Biol Int"},{"key":"30938_CR16","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1093\/nar\/26.23.5243","volume":"26","author":"A Vlassov","year":"1998","unstructured":"Vlassov, A. et al. Characterization and selectivity of catalytic antibodies from human serum with RNase activity. Nucleic Acids Res 26, 5243\u20135250 (1998).","journal-title":"Nucleic Acids Res"},{"key":"30938_CR17","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1126\/science.1062722","volume":"293","author":"P Wentworth Jr.","year":"2001","unstructured":"Wentworth, P. Jr. et al. Antibody catalysis of the oxidation of water. Science 293, 1806\u20131811, https:\/\/doi.org\/10.1126\/science.1062722 (2001).","journal-title":"Science"},{"key":"30938_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/bies.200900020","volume":"31","author":"A Belogurov Jr.","year":"2009","unstructured":"Belogurov, A. Jr., Kozyr, A., Ponomarenko, N. & Gabibov, A. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde. Bioessays 31, 1161\u20131171, https:\/\/doi.org\/10.1002\/bies.200900020 (2009).","journal-title":"Bioessays"},{"key":"30938_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou, C. A., Fugger, L. & Friese, M. A. Immunopathology of multiple sclerosis. Nat Rev Immunol 15, 545\u2013558, https:\/\/doi.org\/10.1038\/nri3871 (2015).","journal-title":"Nat Rev Immunol"},{"key":"30938_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","volume":"15","author":"M Filippi","year":"2016","unstructured":"Filippi, M. et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15, 292\u2013303, https:\/\/doi.org\/10.1016\/S1474-4422(15)00393-2 (2016).","journal-title":"Lancet Neurol"},{"key":"30938_CR21","doi-asserted-by":"publisher","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2 (2017).","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"30938_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald, W. I. et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50, 121\u2013127 (2001).","journal-title":"Ann Neurol"},{"key":"30938_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.09.002","volume":"219","author":"A Awad","year":"2010","unstructured":"Awad, A. et al. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol 219, 1\u20137, https:\/\/doi.org\/10.1016\/j.jneuroim.2009.09.002 (2010).","journal-title":"J Neuroimmunol"},{"key":"30938_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1468-1331.2005.00997.x","volume":"12","author":"I Mayringer","year":"2005","unstructured":"Mayringer, I., Timeltaler, B. & Deisenhammer, F. Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseases. Eur J Neurol 12, 527\u2013530, https:\/\/doi.org\/10.1111\/j.1468-1331.2005.00997.x (2005).","journal-title":"Eur J Neurol"},{"key":"30938_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2017.05.010","volume":"309","author":"C DeMarshall","year":"2017","unstructured":"DeMarshall, C. et al. Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis. J Neuroimmunol 309, 51\u201357, https:\/\/doi.org\/10.1016\/j.jneuroim.2017.05.010 (2017).","journal-title":"J Neuroimmunol"},{"key":"30938_CR26","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0000000000000908","volume":"83","author":"AK Huber","year":"2014","unstructured":"Huber, A. K. et al. Dysregulation of the IL-23\/IL-17 axis and myeloid factors in secondary progressive MS. Neurology 83, 1500\u20131507, https:\/\/doi.org\/10.1212\/WNL.0000000000000908 (2014).","journal-title":"Neurology"},{"key":"30938_CR27","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1212\/WNL.0000000000000905","volume":"83","author":"AM Dickens","year":"2014","unstructured":"Dickens, A. M. et al. A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology 83, 1492\u20131499, https:\/\/doi.org\/10.1212\/WNL.0000000000000905 (2014).","journal-title":"Neurology"},{"key":"30938_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0022-1759(02)00324-1","volume":"269","author":"NA Ponomarenko","year":"2002","unstructured":"Ponomarenko, N. A. et al. Catalytic antibodies in clinical and experimental pathology: human and mouse models. J Immunol Methods 269, 197\u2013211 (2002).","journal-title":"J Immunol Methods"},{"key":"30938_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1073\/pnas.0509849103","volume":"103","author":"NA Ponomarenko","year":"2006","unstructured":"Ponomarenko, N. A. et al. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proceedings of the National Academy of Sciences of the United States of America 103, 281\u2013286, https:\/\/doi.org\/10.1073\/pnas.0509849103 (2006).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"30938_CR30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.4049\/jimmunol.180.2.1258","volume":"180","author":"AA Belogurov Jr","year":"2008","unstructured":"Belogurov, A. A. Jr et al. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol 180, 1258\u20131267 (2008).","journal-title":"J Immunol"},{"key":"30938_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin, F. D. et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83, 278\u2013286, https:\/\/doi.org\/10.1212\/WNL.0000000000000560 (2014).","journal-title":"Neurology"},{"key":"30938_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/intimm\/dxs071","volume":"24","author":"AM Bezuglova","year":"2012","unstructured":"Bezuglova, A. M., Konenkova, L. P., Buneva, V. N. & Nevinsky, G. A. IgGs containing light chains of the lambda- and kappa- type and of all subclasses (IgG1-IgG4) from the sera of patients with systemic lupus erythematosus hydrolyze myelin basic protein. Int Immunol 24, 759\u2013770, https:\/\/doi.org\/10.1093\/intimm\/dxs071 (2012).","journal-title":"Int Immunol"},{"key":"30938_CR33","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/jmr.1143","volume":"24","author":"AM Bezuglova","year":"2011","unstructured":"Bezuglova, A. M., Konenkova, L. P., Doronin, B. M., Buneva, V. N. & Nevinsky, G. A. Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus. J Mol Recognit 24, 960\u2013974, https:\/\/doi.org\/10.1002\/jmr.1143 (2011).","journal-title":"J Mol Recognit"},{"key":"30938_CR34","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1177\/1352458514521517","volume":"20","author":"I Katz Sand","year":"2014","unstructured":"Katz Sand, I., Krieger, S., Farrell, C. & Miller, A. E. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis. Mult Scler 20, 1654\u20131657, https:\/\/doi.org\/10.1177\/1352458514521517 (2014).","journal-title":"Mult Scler"},{"key":"30938_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.07.006","volume":"287","author":"M Gonzalez-Gronow","year":"2015","unstructured":"Gonzalez-Gronow, M. et al. Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus. J Neuroimmunol 287, 1\u20138, https:\/\/doi.org\/10.1016\/j.jneuroim.2015.07.006 (2015).","journal-title":"J Neuroimmunol"},{"key":"30938_CR36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444\u20131452 (1983).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30938-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30938-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30938-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:48:43Z","timestamp":1671612523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30938-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30938"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30938-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12679"}}